Samsung Biologics and Pfizer announce strategic collaboration for long-term manufacturing of biosimilars portfolio June 13, 2023
Bristol Myers Squibb Receives U.S. FDA Approval of New State-of-the-Art Cell Therapy Manufacturing Facility in Devens, Massachusetts June 13, 2023
First Patient Dosed in Ph 1/2 Study of ONCT-808 in patients with R/R aggressive B-cell lymphoma June 13, 2023